AHU377-d4 – 1 mg

Brand:
Cayman
CAS:
1884269-07-1
Storage:
-20
UN-No:
Non-Hazardous - /

AHU377-d4 is intended for use as an internal standard for the quantification of AHU377 (Item No. 21473) by GC- or LC-MS. AHU377 is a methyl ester prodrug form of the neprilysin inhibitor LBQ657 (Item No. 19829).{42277} It increases plasma levels of atrial natriuretic factor (ANF) in conscious rats and anesthetized dogs when administered at doses of 10 and 30 mg/kg, respectively. AHU377 (30 mg/kg) increases ANF-induced urinary sodium excretion in anesthetized rats. Formulations containing AHU377 in combination with valsartan have been used in the treatment of mild to moderate hypertension and chronic heart failure.  

 

Available on backorder

SKU: 25264 - 1 mg Category:

Description

An internal standard for the quantification of AHU377 by GC- or LC-MS,


Formal name: (αR,γS)-γ-[(3-carboxy-1-oxopropyl-2,2,3,3-d4)amino]-α-methyl-[1,1′-biphenyl]-4-pentanoic acid, α-ethyl ester

Synonyms:  Sacubitril-d4

Molecular weight: 415.5

CAS: 1884269-07-1

Purity: ≥99% deuterated forms (d1-d4)

Formulation: A film


Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards||Product Type|Biochemicals|Isotopically Labeled Standards|Deuterium||Product Type|Biochemicals|Small Molecule Inhibitors|MMPs||Research Area|Cardiovascular System|Cardiovascular Diseases|Heart Failure||Research Area|Cardiovascular System|Cardiovascular Diseases|Hypertension||Research Area|Cardiovascular System|Kidney & Renal Disease